Literature DB >> 30451226

Measuring Dengue Virus RNA in the Culture Supernatant of Infected Cells by Real-time Quantitative Polymerase Chain Reaction.

Youichi Suzuki1, Mami Kotoura2, Shun Yashima2, Hong Wu2, Takashi Nakano2, Kouichi Sano2.   

Abstract

At present, real-time polymerase chain reaction (PCR) technology is an indispensable tool for the detection and quantification of viral genomes in research laboratories, as well as for molecular diagnosis, because of its sensitivity, specificity, and convenience. However, in most cases, the quantitative PCR (qPCR) assay generally used to detect virus infection has relied on the purification of viral nucleic acid prior to the PCR step. In this study, the fluorescence-based reverse transcription qPCR (RT-qPCR) assay is developed through the combination of a processing buffer and a one-step RT-PCR reagent so that the whole process, from the harvest of the culture supernatant of virus-infected cells until real-time detection, can be performed without viral RNA purification. The established protocol enables the quantification of a wide range of RNA concentrations of dengue virus (DENV) within 90 min. In addition, the adaptability of the direct RT-qPCR assay to the evaluation of an antiviral agent is demonstrated by an in vitro experiment using a previously reported DENV inhibitor, mycophenolic acid (MPA). Moreover, other RNA viruses, including yellow fever virus (YFV), Chikungunya virus (CHIKV), and measles virus (MeV), can be quantified by direct RT-qPCR with the same protocol. Therefore, the direct RT-qPCR assay described in this report is useful for monitoring RNA virus replication in a simple and rapid manner, which will be further developed into a promising platform for a high-throughput screening study and clinical diagnosis.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30451226     DOI: 10.3791/58407

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  3 in total

1.  Evaluation of Phenol-Substituted Diphyllin Derivatives as Selective Antagonists for Ebola Virus Entry.

Authors:  Caroline B Plescia; Aaron R Lindstrom; Maritza V Quintero; Patrick Keiser; Manu Anantpadma; Robert Davey; Robert V Stahelin; V Jo Davisson
Journal:  ACS Infect Dis       Date:  2022-03-31       Impact factor: 5.578

2.  Identification of potent inhibitors of SARS-CoV-2 infection by combined pharmacological evaluation and cellular network prioritization.

Authors:  J J Patten; Patrick T Keiser; Deisy Morselli-Gysi; Giulia Menichetti; Hiroyuki Mori; Callie J Donahue; Xiao Gan; Italo do Valle; Kathleen Geoghegan-Barek; Manu Anantpadma; RuthMabel Boytz; Jacob L Berrigan; Sarah H Stubbs; Tess Ayazika; Colin O'Leary; Sallieu Jalloh; Florence Wagner; Seyoum Ayehunie; Stephen J Elledge; Deborah Anderson; Joseph Loscalzo; Marinka Zitnik; Suryaram Gummuluru; Mark N Namchuk; Albert-László Barabási; Robert A Davey
Journal:  iScience       Date:  2022-08-13

3.  Direct Lysis RT-qPCR of SARS-CoV-2 in Cell Culture Supernatant Allows for Fast and Accurate Quantification.

Authors:  Nicky Craig; Sarah L Fletcher; Alison Daniels; Caitlin Newman; Marie O'Shea; Wenfang Spring Tan; Amanda Warr; Christine Tait-Burkard
Journal:  Viruses       Date:  2022-02-28       Impact factor: 5.048

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.